Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
1.530
+0.010 (0.66%)
At close: Dec 20, 2024, 4:00 PM
1.580
+0.050 (3.27%)
After-hours: Dec 20, 2024, 7:27 PM EST
Compugen Employees
Compugen had 68 employees as of December 31, 2023. The number of employees decreased by 1 or -1.45% compared to the previous year.
Employees
68
Change (1Y)
-1
Growth (1Y)
-1.45%
Revenue / Employee
$880,176
Profits / Employee
$23,515
Market Cap
136.99M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nevro | 1,215 |
Jin Medical International | 245 |
Metagenomi | 236 |
Puma Biotechnology | 185 |
Seer, Inc. | 147 |
Vaxart | 109 |
Aligos Therapeutics | 66 |
Zura Bio | 15 |
CGEN News
- 24 days ago - Compugen Expands its Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use of COM902 (reduced Fc anti-TIGIT) with anti-PD-1 and anti-PVRIG Antibodies - PRNewsWire
- 5 weeks ago - Compugen Ltd. (CGEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Compugen Reports Third Quarter 2024 Results - PRNewsWire
- 5 weeks ago - Compugen to Participate in Stifel 2024 Healthcare Conference - PRNewsWire
- 6 weeks ago - Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024 - PRNewsWire
- 7 weeks ago - Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - PRNewsWire
- 2 months ago - Compugen to Present New Clinical Data at SITC 2024 - PRNewsWire
- 3 months ago - Compugen to Present at Single Cell Genomics 2024 Conference - PRNewsWire